Copeptin, Procalcitonin and Routine Inflammatory Markers-Predictors of Infection after Stroke

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Fluri, Felix ^a,b   Morgenthaler, Nils G ^c   Mueller, Beat ^d   Christ Crain, Mirjam ^a   Katan, Mira ^b,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; PROCALCITONIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; ERYSIPELAS; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PANNICULITIS; PHLEBITIS; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; SEPSIS; URINARY TRACT INFECTION; VAGINITIS;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CALCITONIN; FEMALE; GLYCOPEPTIDES; HUMANS; INFECTION; INFLAMMATION; MALE; ODDS RATIO; PROGNOSIS; PROTEIN PRECURSORS; STROKE;

EID: 84868267039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048309     Document Type: Article

References (24)

1. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, et al. (2005) The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 36: 1495-1500.
2. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, et al. (2006) Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 37: 461-465.
3. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer MLJ, et al. (2002) Complications following acute ischemic stroke. Eur Neurol 48: 133-140.
4. Chamorro A, Urra X, Planas AM, (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38: 1097-1103.
5. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES, (2000) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638.
6. Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R, et al. (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 32: 552-560.
7. Aslanyan S, Weir CJ, Diener H-C, Kaste M, Lees KR, (2004) Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 11: 49-53.
8. Vermeij FH, Scholte op Reimer WJM, de Man P, van Oostenbrugge RJ, Franke CL, et al. (2009) Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 27: 465-471.
9. Salat D, Delgado P, Alonso S, Ribó M, Santamarina E, et al. (2011) Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients. Eur Neurol 65: 82-87.
10. Emsley HCA, Smith CJ, Tyrrell PJ, Hopkins SJ, (2008) Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care 9: 125-138.
11. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K, (2008) The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 36: 396-407.
12. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, et al. (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11: R38.
13. Katan M, Morgenthaler N, Widmer I, Puder JJ, König C, et al. (2008) Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 29: 341-346.
14. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, et al. (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66: 799-808.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140.
16. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363: 600-607.
17. Morgenthaler NG, Struck J, Alonso C, Bergmann A, (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52: 112-119.
18. Wartenberg KE, Stoll A, Funk A, Meyer A, Schmidt JM, et al. (2011) Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat 2011: 830614.
19. Vogelgesang A, Grunwald U, Langner S, Jack R, Bröker BM, et al. (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39: 237-241.
20. Haeusler KG, Schmidt WUH, Föhring F, Meisel C, Helms T, et al. (2008) Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25: 50-58.
21. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, et al. (2006) Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatr 77: 1279-1281.
22. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, et al. (2007) Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 252: 29-35.
23. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J, (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39: 206-217.
24. Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, et al. (2011) Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 37: 384-392.